Publications by authors named "O O Adewole"
Gender differentials in access to medical services during COVID-19 lockdown: Insights from Nigeria.
Afr J Reprod Health
November 2024
During the COVID-19 pandemic, Nigeria, like many other countries, implemented a lockdown policy that restricted all movement except for essential services. Access to medical services is a critical component of an effective healthcare system, and without equitable access across genders, improving the overall health outcomes of the population is unlikely to be achieved. This study analyses gender differential in access to medical services and sexual reproductive health services namely, family planning, child health, adult health, pharmacy, emergency care, vaccination, and other medical services during the COVID-19 lockdown in Nigeria, using both descriptive and inferential analytical techniques.
View Article and Find Full Text PDFArticle Synopsis
- - Asthma control is vital for reducing health issues and enhancing quality of life, but many patients often misjudge their control levels, leading to a mismatch between their self-assessment and clinical standards set by the Global Initiative for Asthma (GINA).
- - A study involving 100 asthmatic patients in Nigeria found a significant relationship between patients' self-perception and their actual asthma control as defined by GINA, highlighting the discrepancies in understanding among different control levels.
- - While most patients accurately perceived their well-controlled asthma, those in other categories showed less awareness, indicating a need for ongoing patient education to bridge these gaps in understanding asthma management.
Atorvastatin improves sputum conversion and chest X-ray severity score.
Int J Tuberc Lung Dis
December 2023
We report the results of a phase IIB study investigating the safety and effectiveness of atorvastatin use with standard anti-TB drugs. In this multicentre, open-labelled study, we recruited treatment-naÏve patients with uncomplicated pulmonary TB aged at least 18 years. Participants were randomly assigned to standard-of-care or standard-of-care plus oral dose of atorvastatin (40 mg) daily for 2 months.
View Article and Find Full Text PDFIntroduction: Chronic obstructive pulmonary disease (COPD) is a chronic respiratory disorder that affects millions of people worldwide and inhalation therapy is central to the symptomatic management of the disease. Therefore, knowledge of the minimum Peak inspiratory flow (PIF) requirements for specific inhalers especially dry powder inhalers (DPI's) is necessary when prescribing inhalation therapy. The purpose of this study is to assess the effect of COPD severity on PIF in patients with COPD.
View Article and Find Full Text PDF